Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
Vet Q ; 40(1): 108-114, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32194008

RESUMO

Background: Congenital portosystemic shunts (CPSS) are vascular anomalies, allowing portal blood to bypass the hepatic parenchyma, thereby accumulating toxic substances such as ammonia in the systemic circulation resulting in hepatic encephalopathy.Aim: To evaluate the outcome of non-surgically treated dogs with a CPSS.Methods: Case records of 78 dogs with a single congenital CPSS confirmed by ultrasound and/or computed tomography between September 2003 and February 2015 were reviewed. Median age at diagnosis of CPSS in dogs was 10.8 months (range 2-133 months). Non-surgical treatment was started as an adjusted diet (a diet restricted in protein) with or without lactulose. Owners were contacted by telephone to determine survival time and presumed cause of death, if applicable. In addition, a questionnaire was used to retrospectively assess quality of life (QoL) and CPSS scores in 37 dogs before and during non-surgical treatment. Differences between Kaplan-Meier curves were tested by a Log rank test.Results: Overall estimated median survival time (EMST) was 38.5 months (range 1 day - 91 months; 78 dogs). No significant differences between EMSTs were found between dogs with extra- (n = 48) or intrahepatic (n = 29) shunts, nor between treatment with only an adjusted diet, or an adjusted diet combined with lactulose. During non-surgical treatment, significant improvement in perceived QoL and CPSS scores were found (P < 0.01).Conclusion: Our study demonstrated that an overall median EMST of 3.2 years was reached and that owners retrospectively perceived that non-surgical treatment resulted in an improved QoL and clinical performance, irrespective of intrahepatic or extrahepatic CPSS location.


Assuntos
Doenças do Cão/dietoterapia , Doenças do Cão/tratamento farmacológico , Fármacos Gastrointestinais/uso terapêutico , Lactulose/uso terapêutico , Doenças Vasculares/veterinária , Animais , Doenças do Cão/congênito , Doenças do Cão/mortalidade , Cães , Feminino , Encefalopatia Hepática/veterinária , Masculino , Países Baixos/epidemiologia , Qualidade de Vida , Estudos Retrospectivos , Análise de Sobrevida , Resultado do Tratamento , Doenças Vasculares/congênito , Doenças Vasculares/dietoterapia , Doenças Vasculares/mortalidade
2.
Vascul Pharmacol ; 112: 17-23, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-30423448

RESUMO

The role of endothelial metabolism represents a crucial element governing the formation and the differentiation of blood vessels, termed angiogenesis. Besides glycolysis and fatty acid oxidation, endothelial cells rely on specific amino acids to proliferate, migrate, and survive. In this review we focus on the metabolism of those amino acids and the intermediates that hold an established function within angiogenesis and endothelial pathophysiology. We also discuss recent work which provides a rationale for specific amino acid-restricted diets and its beneficial effects on vascular tissues, including extending the life span and preventing the development of a variety of diseases.


Assuntos
Aminoácidos/metabolismo , Células Endoteliais/metabolismo , Endotélio Vascular/metabolismo , Neovascularização Fisiológica , Animais , Dieta com Restrição de Proteínas , Endotélio Vascular/fisiopatologia , Humanos , Transdução de Sinais , Doenças Vasculares/dietoterapia , Doenças Vasculares/metabolismo , Doenças Vasculares/fisiopatologia
3.
Int J Cardiol ; 263: 111-117, 2018 07 15.
Artigo em Inglês | MEDLINE | ID: mdl-29681407

RESUMO

BACKGROUND: Cardiovascular disease is 2-4-fold more prevalent in patients with diabetes. Human studies support the cardiovascular benefits of strawberry consumption but the effects of strawberry on diabetic vasculature are unknown. We tested the hypothesis that dietary strawberry supplementation attenuates vascular inflammation and dysfunction in diabetic mice. METHODS: Seven-week-old diabetic db/db mice that consumed standard diet (db/db) or diet supplemented with 2.35% freeze-dried strawberry (db/db + SB) for ten weeks were compared to non-diabetic control mice (db/+). Indices of vascular inflammation and dysfunction were measured. Endothelial cells (ECs) were isolated from the vasculature to determine the influence of strawberry on them. The effect of metabolites of strawberry on endothelial inflammation was determined by incubating mouse aortic ECs (MAECs) with ±5% serum, obtained from strawberry fed mice (metabolites serum) or standard diet fed mice (control serum) ±â€¯25 mM glucose and 100 µM palmitate. RESULTS: db/db mice exhibited an increased monocyte binding to vessel, elevated blood pressure, and reduced endothelial-dependent vasorelaxation compared with db/+ mice but each defect was attenuated in db/db + SB mice. The elevation of inflammatory molecules, NOX2 and inhibitor-κB kinase observed in ECs from db/db vs. db/+ mice was suppressed in db/db + SB mice. Glucose and palmitate increased endothelial inflammation in MAECs but were normalized by co-incubation with metabolites serum. CONCLUSIONS: Dietary supplementation of strawberry attenuates indices of vascular inflammation and dysfunction in diabetic db/db mice. The effect of strawberry on vasculature is endothelial-dependent and possibly mediated through their circulating metabolites. Strawberry might complement conventional therapies to improve vascular complications in diabetics.


Assuntos
Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/fisiopatologia , Endotélio Vascular/fisiopatologia , Fragaria , Doenças Vasculares/dietoterapia , Doenças Vasculares/fisiopatologia , Animais , Diabetes Mellitus Tipo 2/genética , Suplementos Nutricionais , Inflamação/dietoterapia , Inflamação/genética , Inflamação/fisiopatologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Doenças Vasculares/genética , Vasodilatação/fisiologia
4.
Clin Sci (Lond) ; 131(15): 1941-1953, 2017 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-28620011

RESUMO

DNA damage is an important contributor to endothelial dysfunction and age-related vascular disease. Recently, we demonstrated in a DNA repair-deficient, prematurely aging mouse model (Ercc1Δ/- mice) that dietary restriction (DR) strongly increases life- and health span, including ameliorating endothelial dysfunction, by preserving genomic integrity. In this mouse mutant displaying prominent accelerated, age-dependent endothelial dysfunction we investigated the signaling pathways involved in improved endothelium-mediated vasodilation by DR, and explore the potential role of the renin-angiotensin system (RAS). Ercc1Δ/- mice showed increased blood pressure and decreased aortic relaxations to acetylcholine (ACh) in organ bath experiments. Nitric oxide (NO) signaling and phospho-Ser1177-eNOS were compromised in Ercc1Δ/- DR improved relaxations by increasing prostaglandin-mediated responses. Increase of cyclo-oxygenase 2 and decrease of phosphodiesterase 4B were identified as potential mechanisms. DR also prevented loss of NO signaling in vascular smooth muscle cells and normalized angiotensin II (Ang II) vasoconstrictions, which were increased in Ercc1Δ/- mice. Ercc1Δ/- mutants showed a loss of Ang II type 2 receptor-mediated counter-regulation of Ang II type 1 receptor-induced vasoconstrictions. Chronic losartan treatment effectively decreased blood pressure, but did not improve endothelium-dependent relaxations. This result might relate to the aging-associated loss of treatment efficacy of RAS blockade with respect to endothelial function improvement. In summary, DR effectively prevents endothelium-dependent vasodilator dysfunction by augmenting prostaglandin-mediated responses, whereas chronic Ang II type 1 receptor blockade is ineffective.


Assuntos
Envelhecimento/metabolismo , Dano ao DNA , Receptor Tipo 1 de Angiotensina/metabolismo , Doenças Vasculares/dietoterapia , Envelhecimento/genética , Angiotensina II/metabolismo , Animais , Pressão Sanguínea , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Dieta , Endonucleases/genética , Endonucleases/metabolismo , Feminino , Humanos , Masculino , Camundongos , Camundongos Knockout , Óxido Nítrico/metabolismo , Receptor Tipo 1 de Angiotensina/genética , Doenças Vasculares/genética , Doenças Vasculares/metabolismo , Doenças Vasculares/fisiopatologia , Vasodilatação
5.
Curr Vasc Pharmacol ; 15(4): 291-295, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28056754

RESUMO

BACKGROUND: Gut microbiota is increasingly recognized as a powerful regulator of host physiology. Most of its effects are mediated through metabolites acting as energy sources, signaling receptor ligands and substrates for host enzymes. Owing to the meta-stability and high amenability of the gut microbiota to modification by diet and environment predicting specific gut microbes or its metabolites responsible for different host metabolic states is often confounded. METHODS: The Pubmed was searched for research articles on gut microbiota and cardiovascular disease. RESULTS: The searched articles reported a direct role of gut microbes in cardiovascular disorders (CVD). The interaction among gut microbial metabolism (through breakdown of certain dietary nutrients like choline), host immune system and lipid metabolism generate conditions that promote atherosclerosis development. Importantly, components of this interactive system can be explored to identify points of intervention in the path of disease development. Based on this strategies targeting gut microbial composition and activity are being explored as therapies against CVD. Use of archaebiotics and 3,3-dimethyl- 1-butanol aiming to reduce TMA (trimethylamine) conversion to TMAO (trimethylamine-N-oxide) and high fibre diets to reduce TMA precursors while simultaneously selecting for beneficial gut bacteria are attractive anti-atherogenic approaches. CONCLUSION: Success of these approaches in humans however, requires extensive research.


Assuntos
Microbioma Gastrointestinal , Doenças Vasculares/microbiologia , Animais , Doenças Cardiovasculares/tratamento farmacológico , Doenças Cardiovasculares/microbiologia , Doenças Cardiovasculares/prevenção & controle , Dieta , Humanos , Doenças Vasculares/dietoterapia , Doenças Vasculares/fisiopatologia
6.
Mech Ageing Dev ; 159: 63-70, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-26879630

RESUMO

Ageing is characterized by a decline in all systemic functions. A greater susceptibility to apoptosis and senescence may contribute to proliferative and functional impairment of endothelial progenitor cells. They play an important role in neo-angiogenesis and endothelial repair. Vascular ageing is associated with changes in the structure and functions of vessels' wall. There are many possible causes of this damage. For sure, inflammation and oxidative stress play a fundamental role in the pathogenesis of endothelial dysfunction, commonly attributed to a reduced availability of nitric oxide. Inflammageing, the chronic low-grade inflammation that characterizes elderly people, aggravates vascular pathology and provokes atherosclerosis, the major cardiovascular disease. Nutraceutical and molecular biology represent new insights in this field. In fact, the first could represent a possible treatment in the prevention or delay of vascular ageing; the second could offer new possible targets for potential therapeutic interventions. In this review, we pay attention on the causes of vascular ageing and on the effects of nutraceuticals on it.


Assuntos
Envelhecimento/metabolismo , Dieta Mediterrânea , Células Progenitoras Endoteliais/metabolismo , Doenças Vasculares/dietoterapia , Doenças Vasculares/metabolismo , Envelhecimento/patologia , Células Progenitoras Endoteliais/patologia , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Humanos , Doenças Vasculares/patologia
7.
J Nutr Health Aging ; 20(3): 325-33, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26892582

RESUMO

BACKGROUND AND AIMS: Vitamin K insufficiency is common and linked to an increased risk of cardiovascular disease and osteoporotic fractures. The aim of this study was to examine whether daily supplementation with oral vitamin K could improve vascular health and physical function in older people with established vascular disease. METHODS AND RESULTS: A double blind, randomised, placebo-controlled trial. Participants aged ≤ 70 years with a history of vascular disease were randomised to receive 6 months of daily oral 100mcg vitamin K2 (MK7 subtype) or matching placebo with outcomes measured at 0, 3 and 6 months. The primary outcome was between-group difference in endothelial function assessed using flow-mediated dilatation of the brachial artery at 6 months. Secondary outcomes included carotid-radial pulse wave velocity, augmentation index, blood pressure, carotid intima-media thickness, C-reactive protein, B-type natriuretic peptide, cholesterol and desphospho-uncarboxylated matrix Gla protein levels. Handgrip strength and the Short Physical Performance Battery assessed physical function, while postural sway was measured using a 3-dimensional force platform. RESULTS: 80 participants were randomised, mean age 77 (SD 5) years; 44/80 were male. Vitamin K levels rose in the intervention arm compared to placebo (+48 pg/ml vs -6 pg/ml, p=0.03) at 6 months. Desphospho-uncarboxylated Matrix Gla protein levels fell in the intervention group compared to placebo at 6 months (-130 [SD 117] pmol/L vs +13 [SD 180] pmol/L, p<0.001). No change was seen in endothelial function (between group difference -0.3% [95%CI -1.3 to 0.8], p=0.62). A modest, non-significant improvement in pulse wave velocity was seen in the vitamin K group (-0.8m/s [95%CI -1.8 to 0.3], p=0.15) while all other vascular and physical function outcomes unchanged. CONCLUSIONS: Six months of vitamin K2 supplementation did not improve markers of vascular health or physical function in older patients with vascular disease.


Assuntos
Suplementos Nutricionais , Doenças Vasculares/dietoterapia , Doenças Vasculares/fisiopatologia , Vitamina K/farmacologia , Idoso , Biomarcadores/sangue , Pressão Sanguínea/efeitos dos fármacos , Artéria Braquial/efeitos dos fármacos , Artéria Braquial/fisiopatologia , Proteína C-Reativa/análise , Espessura Intima-Media Carotídea , Colesterol/sangue , Método Duplo-Cego , Feminino , Força da Mão/fisiologia , Humanos , Masculino , Peptídeo Natriurético Encefálico/sangue , Análise de Onda de Pulso , Falha de Tratamento , Vitamina K/administração & dosagem
8.
Br J Nutr ; 113(1): 89-99, 2015 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-25374114

RESUMO

A quality assessment of the primary studies reported in the literature carried out using select dietary ingredients (DI) purported to affect vascular endothelial function was conducted through a systematic PubMed search from January 2000 to August 2012. A total of seventy randomised controlled trials with defined DI (folic acid (fifteen), n-3 fatty acids (twenty), cocoa (fifteen) and isoflavones (twenty)) and standardised measures of vascular endothelial function were evaluated. Jadad scores, quality scoring parameters for DI and flow-mediated dilation (FMD) methodology used were ascertained. A total of 3959 randomised subjects, mean age 51 (se 0·21) years (range 9-79 years), were represented in the dataset. The mean Jadad scores did not differ statistically among the DI studies, with the majority of the studies being of good quality. Higher DI quality scores were achieved by studies using the botanical ingredients cocoa and isoflavones than by those using the nutrient ingredients folic acid and n-3 fatty acids. The mean DI quality scores were 4·13 (se 0·34), 5·20 (se 0·47), 6·13 (se 0·41) and 6·00 (se 0·59) for the folic acid, n-3 fatty acid, cocoa and isoflavone intervention studies, respectively (and significantly different). The mean Corretti FMD scores were 7·27 (se 0·56), 7·46 (se 0·79), 6·29 (se 0·61) and 7·11 (se 0·56) for the folic acid, n-3 fatty acid, cocoa and isoflavone intervention studies, respectively (NS). FMD studies failed to adequately describe the equipment used and more than half failed to provide an adequate description of the procedures used for vascular image acquisition and measurement. DI can be utilised for dietary intervention studies; however, the methodology should be clearly reported using the guidelines for assessment for both DI and FMD.


Assuntos
Confiabilidade dos Dados , Dieta , Doenças Vasculares/dietoterapia , Cacau/química , Endotélio Vascular/metabolismo , Ácidos Graxos Ômega-3/administração & dosagem , Ácido Fólico/administração & dosagem , Humanos , Isoflavonas/administração & dosagem , Metanálise como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Projetos de Pesquisa
9.
Nutrition ; 30(6): 628-35, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24800665

RESUMO

Type 2 diabetes mellitus is a chronic disease characterized by insulin resistance; inflammation; oxidative stress; vascular damage; and dysfunction of glucose, protein, and lipid metabolisms. However, comparatively less attention has been paid to neurologic alterations seen in elderly individuals with type 2 diabetes. We review clinical, metabolic, and biochemical aspects of diabetic encephalopathy (DE) and propose that quality of dietary lipids is closely linked to DE. This implies that preventive nutritional interventions may be designed to improve DE.


Assuntos
Transtornos Cognitivos/fisiopatologia , Cognição , Diabetes Mellitus Tipo 2/fisiopatologia , Animais , Encéfalo/metabolismo , Transtornos Cognitivos/dietoterapia , Transtornos Cognitivos/etiologia , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/dietoterapia , Modelos Animais de Doenças , Humanos , Insulina/metabolismo , Doenças Vasculares/dietoterapia , Doenças Vasculares/etiologia , Doenças Vasculares/fisiopatologia
10.
J Cardiovasc Pharmacol ; 62(2): 111-21, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23599064

RESUMO

The endothelium, a highly active structure, regulates vascular homeostasis through the release of numerous vasoactive factors that control vascular tone and vascular smooth cell proliferation. A larger number of medicinal plants and their isolated chemical constituents have been shown to beneficially affect the endothelium. For example, flavonoids in black tea, green tea, and concord grape cause a vasodilation possibly through their antioxidant properties. Allicin, a by-product of the enzyme alliinase, has been proposed to be the main active metabolite and responsible for most of the biological activities of garlic, including a dose-dependent dilation on the isolated coronaries. Thymoquinone, the principal phytochemical compound found in the volatile oil of the black seed, and the hawthorn extract have also been shown to improve aging-related impairment of endothelium-dependent relaxations in animal models. In this review, the effect of some of the natural products, including Camellia sinensis (black tea and green tea), Vitis labrusca (concord grape), Allium sativum (garlic), and Nigella sativa (black seed) and Crataegus ssp (hawthorn extract), is explored. The molecular mechanisms behind these potential therapeutic effects are also discussed.


Assuntos
Fármacos Cardiovasculares/uso terapêutico , Suplementos Nutricionais , Endotélio Vascular/metabolismo , Modelos Biológicos , Fitoterapia , Extratos Vegetais/uso terapêutico , Doenças Vasculares/prevenção & controle , Animais , Produtos Biológicos/metabolismo , Produtos Biológicos/uso terapêutico , Fármacos Cardiovasculares/metabolismo , Endotélio Vascular/fisiopatologia , Humanos , Extratos Vegetais/metabolismo , Doenças Vasculares/dietoterapia , Doenças Vasculares/metabolismo , Doenças Vasculares/fisiopatologia
11.
Diabetes Obes Metab ; 15(2): 144-52, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22950668

RESUMO

AIMS: The ability of dietary enrichment with monounsaturated fatty acid (MUFA), n-3 or n-6 polyunsaturated fatty acids (PUFAs) to reverse glucose intolerance and vascular dysfunction resulting from excessive dietary saturated fatty acids is not resolved. We hypothesized that partial replacement of dietary saturated fats with n-3 PUFA-enriched menhaden oil (MO) would provide greater improvement in glucose tolerance and vascular function compared to n-6 enriched safflower oil (SO) or MUFA-enriched olive oil (OO). METHODS: We fed mice a high saturated fat diet (HF) (60% kcal from lard) for 12 weeks before substituting half the lard with MO, SO or OO for an additional 4 weeks. At the end of 4 weeks, we assessed glucose tolerance, insulin signalling and reactivity of isolated pressurized gracilis arteries. RESULTS: After 12 weeks of saturated fat diet, body weights were elevated and glucose tolerance was abnormal compared to mice on control diet (13% kcal lard). Diet substituted with MO restored basal glucose levels, glucose tolerance and indices of insulin signalling (phosphorylated Akt) to normal, whereas restoration was limited for SO and OO substitutions. Although dilation to acetylcholine was reduced in arteries from mice on HF, OO and SO diets compared to normal diet, dilation to acetylcholine was fully restored and constriction to phenylephrine was reduced in MO-fed mice compared to normal. CONCLUSION: We conclude that short-term enrichment of an ongoing high fat diet with n-3 PUFA rich MO, but not MUFA rich OO or n-6 PUFA rich SO, reverses glucose tolerance, insulin signalling and vascular dysfunction.


Assuntos
Endotélio Vascular/fisiopatologia , Ácidos Graxos Ômega-3/farmacologia , Ácidos Graxos/farmacologia , Intolerância à Glucose , Resistência à Insulina , Doenças Vasculares/metabolismo , Animais , Peso Corporal , Dieta Hiperlipídica , Gorduras na Dieta , Modelos Animais de Doenças , Endotélio Vascular/metabolismo , Ingestão de Energia , Ácidos Graxos Monoinsaturados/farmacologia , Ácidos Graxos Ômega-3/administração & dosagem , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Azeite de Oliva , Óleos de Plantas , Óleo de Cártamo , Transdução de Sinais , Triglicerídeos/metabolismo , Doenças Vasculares/dietoterapia
12.
Int J Impot Res ; 24(2): 61-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22072232

RESUMO

Oxidative stress and inflammation, which disrupt nitric oxide (NO) production directly or by causing resistance to insulin, are central determinants of vascular diseases including ED. Decreased vascular NO has been linked to abdominal obesity, smoking and high intakes of fat and sugar, which all cause oxidative stress. Men with ED have decreased vascular NO and circulating and cellular antioxidants. Oxidative stress and inflammatory markers are increased in men with ED, and all increase with age. Exercise increases vascular NO, and more frequent erections are correlated with decreased ED, both in part due to stimulation of endothelial NO production by shear stress. Exercise and weight loss increase insulin sensitivity and endothelial NO production. Potent antioxidants or high doses of weaker antioxidants increase vascular NO and improve vascular and erectile function. Antioxidants may be particularly important in men with ED who smoke, are obese or have diabetes. Omega-3 fatty acids reduce inflammatory markers, decrease cardiac death and increase endothelial NO production, and are therefore critical for men with ED who are under age 60 years, and/or have diabetes, hypertension or coronary artery disease, who are at increased risk of serious or even fatal cardiac events. Phosphodiesterase inhibitors have recently been shown to improve antioxidant status and NO production and allow more frequent and sustained penile exercise. Some angiotensin II receptor blockers decrease oxidative stress and improve vascular and erectile function and are therefore preferred choices for lowering blood pressure in men with ED. Lifestyle modifications, including physical and penile-specific exercise, weight loss, omega-3 and folic acid supplements, reduced intakes of fat and sugar, and improved antioxidant status through diet and/or supplements should be integrated into any comprehensive approach to maximizing erectile function, resulting in greater overall success and patient satisfaction, as well as improved vascular health and longevity.


Assuntos
Disfunção Erétil/prevenção & controle , Óxido Nítrico/metabolismo , Envelhecimento/metabolismo , Consumo de Bebidas Alcoólicas , Antagonistas de Receptores de Angiotensina/uso terapêutico , Antioxidantes/uso terapêutico , Dieta com Restrição de Carboidratos , Dieta com Restrição de Gorduras , Disfunção Erétil/dietoterapia , Disfunção Erétil/metabolismo , Exercício Físico , Ácidos Graxos Ômega-3/metabolismo , Humanos , Estilo de Vida , Masculino , Estresse Oxidativo , Inibidores da Fosfodiesterase 5/uso terapêutico , Insuficiência Renal/metabolismo , Abandono do Hábito de Fumar , Testosterona/uso terapêutico , Doenças Vasculares/dietoterapia , Doenças Vasculares/metabolismo , Doenças Vasculares/prevenção & controle , Redução de Peso
13.
Am J Clin Nutr ; 93(2): 446-54, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21147858

RESUMO

BACKGROUND: Although dietary and nutrient interventions have been extensively studied as a means of improving arterial stiffness, to our knowledge no systematic analysis of the data has been conducted. OBJECTIVE: The aim of the current study was to systematically review the human clinical trial data and qualitatively examine the efficacy of dietary and nutrient interventions in the treatment of arterial stiffness. DESIGN: We systematically searched multiple databases until July 2010 for relevant randomized controlled human clinical trials of common dietary and nutrient interventions in the treatment of arterial stiffness. Located studies were subject to strict inclusion criteria and objectively assessed for scientific quality. RESULTS: Of the 75 relevant studies located, we considered 38 studies to be appropriate for review. Results revealed support for intakes of omega-3 (n-3) fish oils (Cohen's d = 0.21-0.81) and soy isoflavones (Cohen's d = 0.35-0.39) in the treatment of arterial stiffness. There was limited but consistent evidence to suggest that salt restriction (Cohen's d = 0.28-0.37) as well as consumption of fermented-milk products (Cohen's d = 0.15-0.33) that contain bioactive peptides improved arterial stiffness. The evidentiary support for intakes of vitamins, micronutrients, and herbal medicines was insufficient. Limited but consistent evidence suggested that caffeine intake acutely increased arterial stiffness (Cohen's d = 0.34-0.51). CONCLUSIONS: Current evidence from several small studies suggests that omega-3 and soy isoflavone supplementation provides an effective means of reducing arterial stiffness. There was little research that explored intakes of herbal medicines or micronutrients in the treatment of arterial stiffness, and this remains an area of potential research.


Assuntos
Artérias/fisiopatologia , Ácidos Graxos Ômega-3/uso terapêutico , Glycine max/química , Isoflavonas/uso terapêutico , Doenças Vasculares/dietoterapia , Resistência Vascular/efeitos dos fármacos , Artérias/efeitos dos fármacos , Cafeína/efeitos adversos , Gorduras na Dieta/uso terapêutico , Ácidos Graxos Ômega-3/farmacologia , Humanos , Isoflavonas/farmacologia , Proteínas do Leite/farmacologia , Proteínas do Leite/uso terapêutico , Fitoterapia , Cloreto de Sódio na Dieta/administração & dosagem , Doenças Vasculares/fisiopatologia
14.
Physiol Behav ; 101(2): 211-7, 2010 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-20416332

RESUMO

The purpose of this study was to investigate effects of Morinda citrifolia fruit juice, which is locally called Noni, on stress-induced impairment of cognitive function. Male ICR mice were divided into four groups: Control (C mice), Restraint stress (RS mice), Restraint+Noni (Noni mice), and Restraint+vitamin E (VE mice). The RS, Noni, and VE mice were subjected to 8h of chronic restraint stress (CRS) 6days a week for 6weeks. During this period, the Noni and VE mice were given a diet supplemented with either Noni or vitamin E, respectively. At Week 5, the mice were subjected to the Morris water maze (MWM) test to measure cognitive function. At Week 7, mouse brains were isolated for immunohistochemical analysis with BrdU or CD31 antibody to assess the proliferation of new cells and blood vessel density in the dentate gyrus of the hippocampus. The time taken to reach the platform in the MWM test was shorter in the Noni mice than in the RS mice on Day 16. Malondialdehyde (MDA ) level of the Noni mice was significantly higher than that of the C mice; however no difference was found in MDA levels between the VE and C mice. Blood vessel area was significantly lower in the R and VE mice than in the C mice; no difference was found between the C and Noni mice. These findings suggest that the administration of Noni fruit juice protects brains from stress-induced impairment of cognitive function and that this protective effect may be related to improvement in stress-induced decreases in blood vessel density in the hippocampal dentate gyrus.


Assuntos
Transtornos Cognitivos/dietoterapia , Transtornos Cognitivos/patologia , Frutas , Morinda , Estresse Psicológico/complicações , Doenças Vasculares/dietoterapia , Análise de Variância , Animais , Peso Corporal/efeitos dos fármacos , Peso Corporal/fisiologia , Bromodesoxiuridina/metabolismo , Córtex Cerebral/metabolismo , Transtornos Cognitivos/etiologia , Modelos Animais de Doenças , Ensaio de Imunoadsorção Enzimática/métodos , Reação de Fuga/efeitos dos fármacos , Reação de Fuga/fisiologia , Hipocampo/metabolismo , Hipocampo/patologia , Peroxidação de Lipídeos/efeitos dos fármacos , Peroxidação de Lipídeos/fisiologia , Masculino , Malondialdeído/metabolismo , Aprendizagem em Labirinto/fisiologia , Camundongos , Camundongos Endogâmicos ICR , Neurogênese/efeitos dos fármacos , Neurogênese/fisiologia , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/fisiologia , Restrição Física/efeitos adversos , Estresse Psicológico/etiologia , Tocoferóis/uso terapêutico , Doenças Vasculares/etiologia , Fator A de Crescimento do Endotélio Vascular/metabolismo
15.
J Mal Vasc ; 35(1): 17-22, 2010 Feb.
Artigo em Francês | MEDLINE | ID: mdl-19959304

RESUMO

Vascular diseases are a major health problem in Western countries. Coronary heart disease (CHD), stroke, and peripheral arterial disease (PAD) share many common risk factors such as age, smoking, dyslipidemia, and diabetes. Although the dietary pattern is considered as a risk factor for CHD, the impact of dietary pattern on stroke and PAD is debated. However, new studies showed that dietary pattern could also be considered as a risk factor in stroke and PAD. Dietary pattern should be evaluated in vascular patients and new tools of dietary assessment must be developed for a better prevention of vascular disease.


Assuntos
Dieta , Avaliação Nutricional , Doenças Vasculares/prevenção & controle , Consumo de Bebidas Alcoólicas , Animais , Arteriosclerose/dietoterapia , Arteriosclerose/etiologia , Arteriosclerose/prevenção & controle , Queijo/efeitos adversos , Doença das Coronárias/dietoterapia , Doença das Coronárias/epidemiologia , Doença das Coronárias/etiologia , Dieta/efeitos adversos , Gorduras na Dieta/efeitos adversos , Gorduras na Dieta/uso terapêutico , Comportamento Alimentar , Peixes , Frutas , Humanos , Carne/efeitos adversos , Educação de Pacientes como Assunto , Doenças Vasculares Periféricas/epidemiologia , Doenças Vasculares Periféricas/etiologia , Papel do Médico , Fatores de Risco , Acidente Vascular Cerebral/epidemiologia , Acidente Vascular Cerebral/etiologia , Doenças Vasculares/dietoterapia , Doenças Vasculares/epidemiologia , Doenças Vasculares/etiologia , Verduras
16.
Circulation ; 119(8): 1161-75, 2009 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-19255356
17.
Curr Opin Endocrinol Diabetes Obes ; 14(5): 365-9, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17940464

RESUMO

PURPOSE OF REVIEW: To review studies of vascular endothelial dysfunction in obesity, discuss potential mechanisms of disease, and address the therapeutic effects of weight loss interventions on arterial health. RECENT FINDINGS: Endothelial dysfunction represents the earliest abnormality in the development of vascular disease, and is pathophysiologically linked to subsequent atherosclerosis progression and cardiovascular disease events. Obesity is closely associated with a number of established cardiovascular risk factors, including diabetes mellitus, insulin resistance, dyslipidemia, and hypertension that are cumulatively damaging to the endothelium. In addition, there is now a growing recognition of non-traditional risk factors as potential modulators of the endothelial phenotype in obesity, including fat tissue production of proatherogenic adipokines, oxidative stress, and chronic inflammation. Clinical studies have demonstrated that even modest weight loss reverses endothelial dysfunction, and the restoration of arterial homeostasis could potentially reduce cardiovascular risk. SUMMARY: Obesity is associated with altered arterial homeostasis and endothelial dysfunction. Mechanisms of disease are related to a complex interplay of metabolic and inflammatory factors that coordinately improve along with arterial function in response to weight loss interventions.


Assuntos
Aterosclerose/etiologia , Endotélio Vascular/fisiopatologia , Obesidade , Adipocinas/efeitos adversos , Adipocinas/imunologia , Adipocinas/metabolismo , Aterosclerose/dietoterapia , Aterosclerose/imunologia , Aterosclerose/fisiopatologia , Doenças Cardiovasculares/dietoterapia , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/imunologia , Doenças Cardiovasculares/fisiopatologia , Doença Crônica/mortalidade , Doença Crônica/prevenção & controle , Diabetes Mellitus/etiologia , Diabetes Mellitus/metabolismo , Endotélio Vascular/imunologia , Homeostase , Humanos , Hiperlipidemias/complicações , Hiperlipidemias/dietoterapia , Hiperlipidemias/imunologia , Hiperlipidemias/metabolismo , Inflamação/etiologia , Inflamação/imunologia , Inflamação/metabolismo , Resistência à Insulina/imunologia , Resistência à Insulina/fisiologia , Obesidade/complicações , Obesidade/dietoterapia , Obesidade/metabolismo , Estresse Oxidativo/imunologia , Fatores de Risco , Comportamento de Redução do Risco , Doenças Vasculares/dietoterapia , Doenças Vasculares/etiologia , Doenças Vasculares/imunologia , Doenças Vasculares/fisiopatologia , Redução de Peso/fisiologia
18.
Minerva Gastroenterol Dietol ; 53(2): 209-13, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17557048

RESUMO

Recurrent abdominal pain (RAP), surely one of the most frequent causes of medical intervention, is frequently present in many gastrointestinal disease. Usually no structural and/or biochemical alterations can be demonstrated. This condition is, therefore, considered to be due to functional disorders such as irritable bowel syndrome (IBS) or functional dyspepsia. Previous observations suggest the presence of a rare alteration of celiac vessels among the possible causes of RAP. This pathological condition was known as Dunbar syndrome. We report 2 cases of chronic abdominal pain. The former reported weight loss and the latter anemia with iron deficiency. It is remarkable that patients with initial diagnosis of IBS can be affected by celiac disease (CD), which is the cause of their abdominal pain. Our patients were tested for CD; the former was negative and IBS was diagnosed, the latter was positive and a gluten free diet was prescribed. The presence of an epigastric bruit, accentuated during expiration, suggested a possible vascular alteration known as tripod celiac artery compression syndrome. Duplex Doppler sonography suggests the diagnosis of celiac arterial constriction due the diaphragmatic ligament. These cases show that tripod celiac artery compression syndrome might be a cause of RAP and that it may be evaluated and investigated when the clinical examination discloses an abdominal systolic bruit.


Assuntos
Dor Abdominal/diagnóstico , Dor Abdominal/etiologia , Artéria Celíaca/patologia , Doenças Vasculares/complicações , Doenças Vasculares/diagnóstico , Dor Abdominal/dietoterapia , Dor Abdominal/cirurgia , Adulto , Artéria Celíaca/diagnóstico por imagem , Doença Crônica , Constrição Patológica/complicações , Constrição Patológica/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Sensibilidade e Especificidade , Síndrome , Resultado do Tratamento , Ultrassonografia Doppler Dupla , Doenças Vasculares/dietoterapia , Doenças Vasculares/cirurgia
19.
Nephrol Dial Transplant ; 22(1): 229-34, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16998212

RESUMO

BACKGROUND: Since it has been demonstrated that soy diet can improve endothelial function, in the present study we evaluated the effect of dietary substitution of 25 g of animal proteins with soy proteins on endothelial dysfunction in renal transplant patients. METHODS: In 20 renal transplant patients (55 +/- 11 years, serum creatinine 1.7 +/- 0.6 mg/dl), brachial artery flow mediated dilation (FMD) and endothelium-independent vasodilation (sublingual nitroglycerine, 25 microg) were measured at baseline, after 5 weeks of a soy diet and finally after 5 weeks of soy wash-out. Changes in plasma lipids, markers of oxidative stress (lipid peroxides, LOOH) and inflammation (C-reactive protein), isoflavones (genistein and daidzein), asymmetric dimethyl arginine (ADMA) and L-arginine were also evaluated. RESULTS: At baseline, patients showed a significantly lower FMD as compared with age-matched healthy subjects (3.2 +/- 1.8 vs 6.3 +/- 1.9, respectively; P < 0.001), while response to nitroglycerine was similar. After soy diet, actual protein intake was not changed, cholesterol and lipid peroxides were significantly reduced, and isoflavones were detectable in plasma. Soy diet was associated with a significant improvement in FMD (4.4 +/- 2.0; P = 0.003 vs baseline), while response to nitroglycerine was unchanged. Improvement in FMD was related to L-arginine/ADMA ratio changes, but no significant relation was found to changes in cholesterol, lipid peroxides or genistein and daidzein plasma concentrations. After 5 weeks of soy diet discontinuation, FMD (3.3 +/- 1.7%) returned to baseline values and isoflavones were no longer detectable in plasma. CONCLUSIONS: A soy protein diet for 5 weeks improves endothelial function in renal transplant patients. This effect seems to be strictly dependent on soy intake as it disappears after soy withdrawal and is mediated by an increase in the L-arginine/ADMA ratio, independently of change in lipid profile, oxidative stress or isoflavones.


Assuntos
Transplante de Rim/métodos , Proteínas de Soja/metabolismo , Doenças Vasculares/dietoterapia , Adulto , Idoso , Proteína C-Reativa/metabolismo , Dieta , Endotélio Vascular/embriologia , Endotélio Vascular/metabolismo , Feminino , Humanos , Nefropatias/metabolismo , Peroxidação de Lipídeos , Masculino , Pessoa de Meia-Idade , Estresse Oxidativo
20.
Clin Exp Pharmacol Physiol ; 33(9): 883-6, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16922826

RESUMO

1. Cardiovascular risk factors associated with the metabolic syndrome affect vascular functions adversely. The aim of the present study was to assess the relationship between parameters of glucose homeostasis and arterial stiffness in women with characteristics of the metabolic syndrome. 2. Twenty post-menopausal women participated in a cross-sectional study in which systemic arterial compliance (SAC) and plasma glucose, lipids and glycosylated haemoglobin (HbA1c) were measured while subjects were maintained on a diet high in fibre, raised in protein and reduced in saturated fat. 3. Regression analysis suggested that mean ( +/-SD) fasting glucose of 5.9 +/- 1.7 mmol/L, glucose levels 2 h after a 75 g glucose load of 6.8 +/- 3.6 mmol/L, systolic blood pressure of 131 +/- 12 mmHg and HbA1c of 5.3 +/- 1.7% predicted SAC negatively. The following correlations were obtained between SAC and: (i) fasting glucose: R = -0.49, P = 0.028; (ii) 2 h glucose level post-glucose load: R = -0.42, P = 0.064; (iii) HbA1c: R = -0.42, P = 0.056; and (iv) systolic blood pressure: R = -0.55, P = 0.012. 4. Relationships between SAC and fasting glucose and systolic blood pressure were significantly independent of each other. There was no evidence of relationships between SAC and any plasma lipid parameter (other than a trend in relation to plasma triglyceride), bodyweight or waist circumference. 5. In conclusion, in post-menopausal women with metabolic syndrome, fasting plasma glucose and systolic blood pressure, and possibly HbA1c and the 2 h glucose post-glucose load, predicted increased arterial stiffness.


Assuntos
Glucose/metabolismo , Síndrome Metabólica/sangue , Resistência Vascular/fisiologia , Idoso , Glicemia/análise , Pressão Sanguínea , Índice de Massa Corporal , Peso Corporal , Colesterol/sangue , Estudos Transversais , Dieta , Feminino , Teste de Tolerância a Glucose , Hemoglobinas Glicadas/análise , Frequência Cardíaca , Humanos , Síndrome Metabólica/dietoterapia , Síndrome Metabólica/fisiopatologia , Pessoa de Meia-Idade , Pós-Menopausa , Triglicerídeos/sangue , Doenças Vasculares/dietoterapia , Doenças Vasculares/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...